Lifecore Biomedical, Inc. approved a new cash incentive plan for executives on September 22, 2025, replacing the previous bonus plan. The new plan focuses 80% on financial performance goals (Adjusted EBITDA and revenue) with potential bonuses capped at 200% of the target based on performance.